Furthermore, exosomal miR-16-5p has the potential to act as a latent inhibitor of tumor growth and serve as a biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma. This evidence concerns the gene CD274 and neoplasm.